[Home] [Back] [Up] [<<] [>>]


Bleeding


Bleeding Assess whether bleeding is spontaneous, or inappropriate and/or excessive in relation to trauma. Note site and nature of bleeding; presence and duration of previous history of surgical, dental, joint, menstrual, mucosal, and skin bleeding; presence of underlying disorder, or use of drugs associated with risk of bleeding. Laboratory testing if indicated; see Figure 1 . See also Bruising , Purpura .
Acquired bleeding disorders Initially - FBC , blood film , platelet count . Additional tests as indicated by the clinical context; see below.
  Advanced and/or metastatic carcinoma See under Carcinoma .
  Blood transfusion related
  DIC
See under Blood transfusion .
  Drug-related bleeding  
    Anticoagulant therapy See Anticoagulant monitoring .
    Fibrinolytic therapy See Thrombolytic therapy .
    Aspirin, other NSAID Predictable abnormality of bleeding time and platelet aggregation; these tests do not predict the risk of bleeding and are not indicated.
    Thrombocytopenia  
  Liver disease See Bleeding under Cirrhosis - consequences.
  Multiple myeloma  
  Myeloproliferative disorders esp  
    Essential Thrombocythaemia
    Myelofibrosis
 
  Neonatal bleeding  
  Obstetric (peripartum) bleeding See under Pregnancy .
  Paraproteinaemia  
  Renal failure See Bleeding under Renal failure - chronic (complications).
  Rodenticide poisoning See under Poisoning .
  SLE  
  Thrombocytopenia  
Inherited bleeding disorders

There is usually a personal and/or family history of bleeding. Mild disorders may present as surgical or dental bleeding in the adult. Initially - FBC , platelet count , blood film ; PT , APTT . Normal results do not exclude the possibility of a clinically significant inherited bleeding disorder and further investigation should be determined on the basis of the history. The bleeding time has little place in this initial assessment; consult pathologist. Further tests as indicated from the initial results, and as appropriate to the history and the degree of clinical suspicion. See Figure 1 .
  von Willebrands disease  
  Haemophilia A See under Haemophilia .
  Haemophilia B See under Haemophilia .
  Factor XI deficiency Coagulation factors (XI) assay.
  Factor XII deficiency Coagulation factors (XII) assay; this deficiency is not associated with an increased risk of bleeding.
  Factor XIII deficiency Factor XIII screening test; consult pathologist.
  Hypofibrinogenaemia/ afibrinogenaemia Thrombin time , fibrinogen assay .
  Dysfibrinogenaemia Thrombin time , reptilase time ; consult pathologist.
  Other inherited coagulation disorders Rare; consult pathologist.
  Inherited disorders of platelet function A normal bleeding time does not exclude a clinically significant disorder of platelet function.
    Release disorders eg Platelet aggregation/release studies. For definitive platelet membrane, granule, and prostaglandin studies - consult pathologist.
      Storage pool disease
    Thrombasthenia
    Bernard Soulier syndrome
  Hereditary haemorrhagic telangiectasia   Clinical diagnosis. Mucocutaneous telangiectases with recurrent bleeding from mucosal surfaces. See also Telangiectases .
  Collagen disorders The bleeding time may be prolonged.





[Home] [Back] [Up] [<<] [>>]